Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of Trivalent Live-Attenuated Influenza Vaccine in Senegalese Children
NCT01854632Phase 3Completed
- Sponsor
- PATH
- Start
- May 2013
- Primary completion
- Dec 2013
- Modality
- Live Attenuated Vaccines
- Countries
- 1
01
Overview
A Phase 3 trial of Ganwu in influenza, sponsored by PATH. Started May 2013; status: completed.
02
Drugs
Ganwu
03
Conditions
influenza
Beyond the preview
Go deeper on NCT01854632.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01854632.